Asahi Kasei Corporation

OTCPK:AHKS.F Stock Report

Market Cap: US$9.8b

Asahi Kasei Valuation

Is AHKS.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AHKS.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AHKS.F ($7.13) is trading below our estimate of fair value ($9.82)

Significantly Below Fair Value: AHKS.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AHKS.F?

Key metric: As AHKS.F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for AHKS.F. This is calculated by dividing AHKS.F's market cap by their current earnings.
What is AHKS.F's PE Ratio?
PE Ratio20.3x
EarningsJP¥73.21b
Market CapJP¥1.48t

Price to Earnings Ratio vs Peers

How does AHKS.F's PE Ratio compare to its peers?

The above table shows the PE ratio for AHKS.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average58x
CBT Cabot
15.9xn/aUS$6.0b
WLK Westlake
170.6x54.6%US$16.5b
OLN Olin
33x62.8%US$5.0b
LYB LyondellBasell Industries
12.6x10.9%US$27.0b
AHKS.F Asahi Kasei
20.3x18.3%US$1.5t

Price-To-Earnings vs Peers: AHKS.F is good value based on its Price-To-Earnings Ratio (20.3x) compared to the peer average (58x).

Price to Earnings Ratio vs Industry

How does AHKS.F's PE Ratio compare vs other companies in the US Chemicals Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FFHL Fuwei Films (Holdings)
2.8xn/aUS$27.11m
BSLK Bolt Projects Holdings
0.06xn/aUS$9.57m
BON Bon Natural Life
3xn/aUS$7.35m
GSPI Green Star Products
1.7xn/aUS$1.64m
AHKS.F 20.3xIndustry Avg. 22.7xNo. of Companies8PE01224364860+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: AHKS.F is good value based on its Price-To-Earnings Ratio (20.3x) compared to the US Chemicals industry average (22.7x).

Price to Earnings Ratio vs Fair Ratio

What is AHKS.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AHKS.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.3x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AHKS.F's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AHKS.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$8.47
0%
12.4%US$10.67US$7.18n/a11
Nov ’25US$6.55
US$8.52
+30.0%
12.4%US$10.46US$7.26n/a11
Oct ’25n/a
US$8.85
0%
14.6%US$11.13US$7.10n/a10
Sep ’25n/a
US$8.65
0%
15.4%US$11.01US$7.02n/a10
Aug ’25US$7.15
US$8.27
+15.7%
13.5%US$10.02US$6.81n/a10
Jul ’25US$6.45
US$7.33
+13.6%
10.3%US$8.93US$6.38n/a10
Jun ’25US$6.56
US$7.29
+11.2%
9.5%US$8.61US$6.38n/a10
May ’25US$7.10
US$7.35
+3.5%
11.4%US$8.91US$6.40n/a10
Apr ’25US$7.19
US$7.35
+2.1%
11.4%US$8.91US$6.40n/a10
Mar ’25US$7.09
US$7.31
+3.1%
10.2%US$8.97US$6.44n/a9
Feb ’25US$7.46
US$7.49
+0.4%
12.3%US$9.60US$6.38n/a9
Jan ’25n/a
US$7.53
0%
12.5%US$9.84US$6.54n/a10
Dec ’24US$6.72
US$7.00
+4.1%
12.8%US$9.49US$6.10n/a11
Nov ’24US$6.05
US$6.67
+10.3%
11.8%US$8.98US$5.98US$6.5511
Oct ’24US$6.35
US$6.72
+5.8%
12.3%US$9.03US$6.02n/a10
Sep ’24US$6.58
US$6.90
+5.0%
12.2%US$9.21US$6.07n/a10
Aug ’24US$6.62
US$7.17
+8.2%
11.6%US$9.42US$6.21US$7.1510
Jul ’24US$6.72
US$7.22
+7.4%
12.7%US$9.63US$6.35US$6.4510
Jun ’24US$6.74
US$7.14
+6.0%
14.2%US$9.63US$5.56US$6.5610
May ’24US$7.08
US$7.36
+4.0%
13.8%US$9.72US$5.83US$7.1010
Apr ’24US$7.07
US$7.72
+9.3%
13.9%US$9.94US$5.97US$7.199
Mar ’24US$6.93
US$7.48
+8.0%
11.8%US$9.53US$6.30US$7.0910
Feb ’24US$7.59
US$8.38
+10.5%
17.4%US$12.09US$6.71US$7.4610
Jan ’24US$7.31
US$8.49
+16.2%
17.7%US$11.71US$7.10n/a10
Dec ’23US$7.34
US$8.53
+16.2%
15.2%US$11.45US$6.95US$6.7211
Nov ’23US$6.47
US$7.90
+22.2%
17.4%US$11.01US$6.27US$6.0511

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Ecora Resources

UK£163.3m

Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.

ECRA.F

UK£0.81

7D

-1.1%

1Y

-28.7%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.16

7D

-0.5%

1Y

25.2%

CMOC Group

HK$156.5b

Engages in the mining, beneficiation, smelting, and refining of base and rare metals.

CMCL.F

HK$0.70

7D

-9.4%

1Y

27.9%